0001062993-23-008102.txt : 20230330 0001062993-23-008102.hdr.sgml : 20230330 20230330173949 ACCESSION NUMBER: 0001062993-23-008102 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230328 FILED AS OF DATE: 20230330 DATE AS OF CHANGE: 20230330 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KIM DENNIS D CENTRAL INDEX KEY: 0001456750 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36500 FILM NUMBER: 23782001 MAIL ADDRESS: STREET 1: C/O EMERALD BIOSCIENCE, INC. STREET 2: 130 NORTH MARINA DRIVE CITY: LONG BEACH STATE: CA ZIP: 90803 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CymaBay Therapeutics, Inc. CENTRAL INDEX KEY: 0001042074 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943103561 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 7575 GATEWAY BOULEVARD STREET 2: SUITE 110 CITY: NEWARK STATE: CA ZIP: 94560 BUSINESS PHONE: 510-293-8800 MAIL ADDRESS: STREET 1: 7575 GATEWAY BOULEVARD STREET 2: SUITE 110 CITY: NEWARK STATE: CA ZIP: 94560 FORMER COMPANY: FORMER CONFORMED NAME: METABOLEX, INC. DATE OF NAME CHANGE: 20090721 FORMER COMPANY: FORMER CONFORMED NAME: METABOLEX INC DATE OF NAME CHANGE: 19970710 4 1 form4.xml STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES X0407 4 2023-03-28 0001042074 CymaBay Therapeutics, Inc. CBAY 0001456750 KIM DENNIS D C/O CYMABAY THERAPEUTICS, INC. 7575 GATEWAY BLVD., SUITE 110 NEWARK CA 94560 0 1 0 0 Chief Medical Officer 0 Common Stock 2023-03-28 4 M 0 100 4.37 A 20100 D Common Stock 2023-03-28 4 S 0 100 8.985 D 20000 D Employee Stock Option (right to buy) 4.37 2023-03-28 4 M 0 100 0 D 2031-05-16 Common Stock 100 289900 D The original option grant vested as to 1/4 of the underlying shares on May 17, 2022 and vests as to 1/48 of the underlying shares monthly thereafter. /s/ Paul Quinlan, as attorney-in-fact for Dennis D. Kim 2023-03-30